ES8707107A1 - Un procedimiento para la fabricacion de una composicion a base de antralina, util para el tratamiento topico de la psoriasis. - Google Patents

Un procedimiento para la fabricacion de una composicion a base de antralina, util para el tratamiento topico de la psoriasis.

Info

Publication number
ES8707107A1
ES8707107A1 ES533186A ES533186A ES8707107A1 ES 8707107 A1 ES8707107 A1 ES 8707107A1 ES 533186 A ES533186 A ES 533186A ES 533186 A ES533186 A ES 533186A ES 8707107 A1 ES8707107 A1 ES 8707107A1
Authority
ES
Spain
Prior art keywords
compositions
anionic surfactant
stabilization
acid
bisulphites
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES533186A
Other languages
English (en)
Other versions
ES533186A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of ES533186A0 publication Critical patent/ES533186A0/es
Publication of ES8707107A1 publication Critical patent/ES8707107A1/es
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

METODO DE FABRICAR UNA COMPOSICION A BASE DE ANTRALINA. CONSISTE EN: A) MEZCLAR EN UNA VASIJA EN UNA FASE OLEOSA QUE COMPRENDE ACEITE MINERAL, GALATO DE PROPILO, BHT, ACIDO SALICILICO, OLETH-2, ISOCETETH-20, PALMITATO DE ASCORBILO Y ANTRALINA; B) MEZCLAR EN UNA SEGUNDA VASIJA EN UNA FASE ACUOSA QUE COMPRENDE PEG-8, SOLUCION DE SORBITOL AL 70%, EDTA, BISULFITO SODICO, ACIDO ASCORBICO, AGUA Y UN SURFACTANTE ANIONICO SOLUBLE EN AGUA Y ESTABLE A LOS ACIDOS; C) COMBINAR LAS FASES OLEOSA Y ACUOSA DE LAS ETAPAS (A) Y (B) CON SUFICIENTE CALENTAMIENTO Y MEZCLADO; Y D) ENFRIAR EL PRODUCTO DE LA ETAPA (C) HASTA LA TEMPERATURA AMBIENTE. TIENE APLICACIONES EN EL TRATAMIENTO TOPICO DE LA PSORIASIS.
ES533186A 1983-06-09 1984-06-06 Un procedimiento para la fabricacion de una composicion a base de antralina, util para el tratamiento topico de la psoriasis. Expired ES8707107A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50285283A 1983-06-09 1983-06-09

Publications (2)

Publication Number Publication Date
ES533186A0 ES533186A0 (es) 1987-07-16
ES8707107A1 true ES8707107A1 (es) 1987-07-16

Family

ID=23999686

Family Applications (1)

Application Number Title Priority Date Filing Date
ES533186A Expired ES8707107A1 (es) 1983-06-09 1984-06-06 Un procedimiento para la fabricacion de una composicion a base de antralina, util para el tratamiento topico de la psoriasis.

Country Status (21)

Country Link
JP (1) JPS608222A (es)
AT (1) AT393959B (es)
AU (1) AU569085B2 (es)
BE (1) BE899874A (es)
CH (1) CH659945A5 (es)
CY (1) CY1531A (es)
DE (1) DE3421510A1 (es)
DK (1) DK163028C (es)
ES (1) ES8707107A1 (es)
FI (1) FI83837C (es)
FR (1) FR2547725B1 (es)
GB (1) GB2142534B (es)
HK (1) HK66490A (es)
IE (1) IE57562B1 (es)
IT (1) IT1183058B (es)
LU (1) LU85411A1 (es)
NO (1) NO171623C (es)
NZ (1) NZ208338A (es)
OA (1) OA07720A (es)
PT (1) PT78713A (es)
SE (1) SE465205B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4551480A (en) * 1983-06-21 1985-11-05 Stiefel Laboratories, Inc. Compositions for the treatment of psoriasis
DE3413569A1 (de) * 1984-04-11 1985-10-24 Röhm Pharma GmbH, 6108 Weiterstadt Pharmazeutisches mittel zur psoriasis-therapie
GB8729855D0 (en) * 1987-12-22 1988-02-03 Drythanol Ltd New dithranol compositions
AT408067B (de) * 1995-03-17 2001-08-27 Gebro Pharma Gmbh Pharmazeutische zusammensetzung zur topischen applizierung und verfahren zu ihrer herstellung

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1070949A (en) * 1964-10-16 1967-06-07 Hyman Yarrow Topical compositions for the treatment of psoriasis
GB1574090A (en) * 1977-07-06 1980-09-03 Drythanol Ltd Dithranol composition for the treatment of psoriasis
DE3008805A1 (de) * 1980-03-07 1981-09-24 Paul 8501 Oberasbach Unger Skibremse
CH655004A5 (fr) * 1981-10-23 1986-03-27 Oreal Composition anhydre, stable a l'oxydation, d'un compose d'anthraline dans un alkyl-ester d'acide gras en vue du traitement des maladies de la peau.
FR2520233A1 (fr) * 1982-01-28 1983-07-29 Oreal Composition d'anthraline ou de l'un de ses derives dans un ester aromatique et son utilisation dans le traitement des maladies de la peau
FR2526321A1 (fr) * 1982-05-10 1983-11-10 Salomon & Fils F Frein de ski

Also Published As

Publication number Publication date
SE8403110L (sv) 1984-12-10
GB2142534B (en) 1987-06-03
NO171623B (no) 1993-01-04
GB8414653D0 (en) 1984-07-11
FI83837C (fi) 1991-09-10
DK163028C (da) 1992-06-09
DK283884A (da) 1984-12-10
FI83837B (fi) 1991-05-31
ES533186A0 (es) 1987-07-16
DK283884D0 (da) 1984-06-08
FR2547725B1 (fr) 1987-12-04
NZ208338A (en) 1987-11-27
JPS608222A (ja) 1985-01-17
SE465205B (sv) 1991-08-12
PT78713A (en) 1984-07-01
AT393959B (de) 1992-01-10
FI842274A (fi) 1984-12-10
DK163028B (da) 1992-01-13
CY1531A (en) 1990-11-16
IT8421331A0 (it) 1984-06-08
FR2547725A1 (fr) 1984-12-28
IE841440L (en) 1984-12-09
OA07720A (fr) 1985-08-30
ATA189784A (de) 1991-07-15
DE3421510A1 (de) 1984-12-20
NO842326L (no) 1984-12-10
AU569085B2 (en) 1988-01-21
IT1183058B (it) 1987-10-05
NO171623C (no) 1993-04-21
LU85411A1 (fr) 1985-03-26
SE8403110D0 (sv) 1984-06-08
IE57562B1 (en) 1992-12-16
BE899874A (fr) 1984-12-10
AU2923784A (en) 1984-12-13
GB2142534A (en) 1985-01-23
FI842274A0 (fi) 1984-06-06
HK66490A (en) 1990-08-31
CH659945A5 (de) 1987-03-13

Similar Documents

Publication Publication Date Title
ES2104605T3 (es) Composiciones estables de acido ascorbico.
IT1203515B (it) Complessi di saponine con fosfolipidi e composizioni farmaceutiche e cosmetiche che li contengono
DK0730441T3 (da) Deskvamationspræparater, der indeholder salicylsyre og zwitterioniske forbindelser
GR3003631T3 (es)
EP0156924A4 (en) CHEMICALLY ACTIVE COMPOSITION CONTAINING FERROUS IONS.
JO1273B1 (en) Compounds and Substitutes -2,3,4,5, Tetra-Idol-3-Benzazinate
ES2085345T3 (es) Mejora de las funciones reproductoras en mamiferos
ATE42316T1 (de) Phosphorsaeureesterverbindung.
EP0158212A3 (en) Citric-acid esters as blowing agents for working up plastics
ES8707107A1 (es) Un procedimiento para la fabricacion de una composicion a base de antralina, util para el tratamiento topico de la psoriasis.
ES2089560T3 (es) Preparados cosmeticos y dermatologicos.
JPS52136159A (en) Anti/malignanttumor containing the same as active ingredients
ZA91115B (en) Topical compositions
ATE174383T1 (de) Verwendung von tri-n-butylphosphat bei niedrigem ph in lösungen von biologisch aktiven proteinen für eine verbesserte viruzide wirkung
ES2037691T3 (es) Colirio liquido preparado con un contenido de acido cromoglicinico.
ES2000033A6 (es) Composicion de bitionol sulfoxido porcedimiento para su fabricacion y metodo de utilizacion de aquella
JPS52108088A (en) Preparation of monohydroxycarboxylic acid using microbials
AU559302B2 (en) Ammonium and aklylolammonium alkyl sulphate surfactants
AU554432B2 (en) High concentration amine oxide formulations
TR23745A (tr) 1-dimetilkarbomoil-3-suebstituee 1h-1.2.4-triazoller
BG29273A3 (en) Acaricide meang and method for acari fighting
ES8702162A1 (es) Procedimiento para preparar composiciones autoemulsionables a base de fluoroclorohidrocarburos y de esteres fosforicos
JPS53101536A (en) Antiallergics
BG52067B2 (en) Antihypoxic and brain-protection antidote composition
ES8605755A1 (es) Procedimiento para la preparacion de una composicion fungi- cida para el tratamiento de infecciones producidas por hon- gos en plantas cultivadas

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970519